Europe approves high-price gene therapy | Reduction

Europe approves high-price gene therapy

Diagnosing the dummy by Ano Lobb. @healthyrx
License (according to Flickr): Attribution License

Excerpt:

European authorities have actually approved the Western globe 's first gene therapy medicine from a small Dutch biotech business, in a milestone for the novel medical innovation that fixes defective genes. The formal clearance from the European Commission breaks the ice for a launch following summer season of the treatment for an ultra uncommon genetic disease that will cost around 1. 2 million euros ($ 1. 6 million) per client, a brand-new record for costly modern medicines. After more than 20 years of experiments and a collection of frustrations, the EU approval of Glybera, which deals with the genetic condition lipoprotein lipase deficiency (LPLD), is a substantial boost for the gene therapy industry.

Concepts:

Severe combined immunodeficiency European Union Genetics Medicine European Commission Disease Gaucher's disease Lipoprotein lipase deficiency

People:

Joern Aldag

Overall Sentiment: 0.131716

Relevance: 0.942787

Additional Info:

HealthCondition: Gaucher disease

Overall Sentiment: -0.211369

Relevance: 0.669421

Disambiguation: DiseaseOrMedicalCondition | DiseaseCause | RiskFactor | DiseaseReferences:

• Gaucher's disease: dbpedia
• Gaucher's disease: freebase
• Gaucher's disease: yago

HealthCondition: bubble boy disease

Overall Sentiment: -0.0659909

Relevance: 0.543082

HealthCondition: severe combined immunodeficiency

Overall Sentiment: 0.0360891

Relevance: 0.522737

Disambiguation: DiseaseOrMedicalCondition | DiseaseReferences:

• Severe combined immunodeficiency: dbpedia
• Severe combined immunodeficiency: freebase
• Severe combined immunodeficiency: yago

HealthCondition: cancer

Overall Sentiment: 0.314615

Relevance: 0.44843

Disambiguation: FieldOfStudy | DiseaseOrMedicalCondition | CauseOfDeath | DiseaseCause | MedicalSpecialty | RiskFactor | DiseaseReferences:

• Cancer: dbpedia
• Cancer: freebase
• Cancer: opencyc

HealthCondition: leukaemia

Overall Sentiment: -0.0617773

Relevance: 0.425668

FieldTerminology: large pharmaceutical companies

Overall Sentiment: 0

Relevance: 0.497438

Drug: Cerezyme

Overall Sentiment: -0.184838

Relevance: 0.477685

Country: United States

Overall Sentiment: 0.138442

Relevance: 0.564574

Disambiguation: Location | Region | AdministrativeDivision | GovernmentalJurisdiction | FilmEditorReferences:

• United States
• United States: dbpedia
• United States: freebase
• United States: ciaFactbook
• United States: opencyc
• United States: yago

Country: China

Overall Sentiment: 0.263093

Relevance: 0.464979

Disambiguation: References:

• Republic of China: dbpedia
• Republic of China: freebase
• Republic of China: umbel
• Republic of China: yago

Country: Canada

Overall Sentiment: 0.142358

Relevance: 0.407648

Disambiguation: Location | GovernmentalJurisdiction | Kingdom | AwardDiscipline | FilmScreeningVenueReferences:

• Canada
• Canada: dbpedia
• Canada: freebase
• Canada: ciaFactbook
• Canada: umbel
• Canada: opencyc
• Canada: yago

City: Shenzhen

Overall Sentiment: 0.320457

Relevance: 0.488157

Disambiguation: AdministrativeDivisionReferences:

• Shenzhen
• Shenzhen: dbpedia
• Shenzhen: freebase
• Shenzhen: geonames
• Shenzhen: yago

StateOrCounty: Arizona

Overall Sentiment: -0.396373

Relevance: 0.47015

Disambiguation: Location | PoliticalDistrict | AdministrativeDivision | GovernmentalJurisdiction | USStateReferences:

• Arizona
• Arizona: dbpedia
• Arizona: freebase
• Arizona: umbel
• Arizona: opencyc
• Arizona: census
• Arizona: yago

Continent: Europe

Overall Sentiment: 0.017267

Relevance: 0.463581

Disambiguation: References:

• Europe: dbpedia
• Europe: freebase
• Europe: yago

Organization: European Medicines Agency

Overall Sentiment: 0.562737

Relevance: 0.580088

Organization: European Commission

Overall Sentiment: 0.354564

Relevance: 0.578456

Organization: EU

Overall Sentiment: 0.166115

Relevance: 0.513064

Disambiguation: Location | Country | GovernmentalJurisdiction | MembershipOrganization | AwardWinnerReferences:

• European Union: dbpedia
• European Union: freebase
• European Union: ciaFactbook
• European Union: umbel
• European Union: opencyc
• European Union: yago

Organization: LPLD

Overall Sentiment: -0.172231

Relevance: 0.480844

Company: GlaxoSmithKline

Overall Sentiment: 0.0670377

Relevance: 0.513671

Disambiguation: References:

• GlaxoSmithKline
• GlaxoSmithKline: dbpedia
• GlaxoSmithKline: freebase
• GlaxoSmithKline: umbel
• GlaxoSmithKline: yago
• GlaxoSmithKline: crunchbase
• GlaxoSmithKline: semanticCrunchbase

Company: Sanofi

Overall Sentiment: -0.110053

Relevance: 0.456514

Disambiguation: References:

• Sanofi-Aventis
• Sanofi-Aventis: dbpedia
• Sanofi-Aventis: freebase
• Sanofi-Aventis: umbel
• Sanofi-Aventis: yago

Company: Genzyme

Overall Sentiment: -0.0838776

Relevance: 0.433693

Disambiguation: VentureFundedCompanyReferences:

• Genzyme
• Genzyme: dbpedia
• Genzyme: freebase
• Genzyme: umbel
• Genzyme: opencyc
• Genzyme: yago

Site Tags Info

Source URL: Click Here

Webpage Provided Keywords:

• Arizona
• biotech
• biotech company
• Canada
• China
• gene therapy
• genetic disease
• genetic disorder
• medical technology
• potentially fatal
• rare diseases
• replacement therapies
• technology
• the time
• United States

Webpage Provided Desc:

European officials have approved the Western world's first gene therapy drug from a small Dutch biotech company, in a milestone for the novel medical technology that fixes faulty genes

URL Provided Title:

Europe approves high-price gene therapy

Data Sources

Full Content: http://feeds.foxnews.com/~r/foxnews/health/~3/SrX2t-uYf_w/

Click